Phase II clinical trial of atezolizumab (A) in advanced non-small cell lung cancer (NSCLC) patients (pts) previously treated with PD1-directed therapy Meeting Abstract

Industry Collaboration

cited authors

  • Bhattacharya, Saveri; Yun, Cindy; Schulze, Katja; Bruno, Tullia C.; Kurland, Brenda F.; Socinski, Mark A.; Villaruz, Liza Cosca

authors

Publication Date

  • May 20, 2017

webpage

published in

category

volume

  • 35